Skip to content

Drug interactions

Netupitant-palonosetron + Tecovirimat

Severity: Minor

Netupitant-palonosetron and Tecovirimat: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tecovirimat is a weak CYP3A4 inducer and may modestly lower netupitant concentrations. This could in theory reduce antiemetic effectiveness, though the effect is likely small.

What this interaction means in plain words

Netupitant-palonosetron and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Netupitant-palonosetron belongs to Gastrointestinal Tract; Tecovirimat belongs to Miscellaneous.

Evidence level: Low

Why it happens

Tecovirimat weakly induces CYP3A4, increasing netupitant metabolism.

What to do

No dose adjustment is needed. Monitor for breakthrough nausea and vomiting and treat with rescue antiemetics if needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Netupitant-palonosetron and Tecovirimat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Netupitant-palonosetron with Tecovirimat?

MediHelp rates the interaction as minor. Netupitant-palonosetron and Tecovirimat have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tecovirimat is a weak CYP3A4 inducer and may modestly lower netupitant concentrations. This could in theory reduce antiemetic effectiveness, though the effect is likely small.

How serious is the interaction between Netupitant-palonosetron and Tecovirimat?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed. Monitor for breakthrough nausea and vomiting and treat with rescue antiemetics if needed.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in